MetaCap

CAMP4 Therapeutics Insider Trades

NASDAQ: CAMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.79-0.21 (-5.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $99.05K
Sales
6 · $2.50M
Shares bought / sold
46.03K / 593.61K
Net activity
Net selling $2.4 million

CAMP4 Therapeutics insider activity

Over the last 12 months, CAMP4 Therapeutics insiders reported 11 transactions on SEC Form 4: 5 open-market purchases and 6 sales. Insiders bought $99,051 and sold $2.5 million worth of stock, for net insider selling of $2.4 million. The largest seller was Schwab Andrew J., with $2.5 million in reported sales.

The most recent filing shows Gold Kelly (Chief Financial Officer) buying 10,000 shares at $3.96 on Aug 31, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CAMP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CAMP insider transactions

CAMP4 Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Aug 31, 2026Gold KellyChief Financial OfficerBuy10,000$39.60KForm 4
Aug 27, 2026Schwab Andrew J.DirectorSale400,000$1.62MForm 4
Aug 24, 2026Schwab Andrew J.DirectorSale10$45Form 4
Aug 21, 2026Schwab Andrew J.DirectorSale32,018$144.08KForm 4
Aug 20, 2026Schwab Andrew J.DirectorSale114,700$520.74KForm 4
Aug 19, 2026Tardiff DanielChief Scientific OfficerSale1,738$8.27KForm 4
Aug 19, 2026Schwab Andrew J.DirectorSale45,147$214.90KForm 4
Aug 3, 2026Gold KellyChief Financial OfficerBuy6,551$10.81KForm 4
Aug 3, 2026Maricich YuriChief Medical OfficerBuy6,551$10.81KForm 4
Aug 3, 2026Mandel-Brehm JoshChief Executive OfficerBuy6,551$10.81KForm 4
Aug 3, 2026Young Richard ADirectorBuy16,378$27.02KForm 4
Sep 11, 2025Young Richard ADirectorBuy15,151$25.00KForm 4
Sep 11, 2025Maricich YuriChief Medical OfficerBuy6,060$10.00KForm 4
Sep 11, 2025Nashat AmirDirectorBuy85,468$130.77KForm 4
Sep 11, 2025Nashat AmirDirectorBuy1,221,721$1.87MForm 4
Sep 11, 2025Polaris Management Co. VII, L.L.C. & Polaris Partners VII, L.P. & Polaris Entrepreneurs' Fund VII, L.P. & Polaris Partners X, L.P. & Polaris Partners GP X, L.L.C. & SCHULMAN AMY W & Chee Brian10% OwnerBuy85,468$130.77KForm 4
Sep 11, 2025Polaris Management Co. VII, L.L.C. & Polaris Partners VII, L.P. & Polaris Entrepreneurs' Fund VII, L.P. & Polaris Partners X, L.P. & Polaris Partners GP X, L.L.C. & SCHULMAN AMY W & Chee Brian10% OwnerBuy1,221,721$1.87MForm 4
Sep 11, 2025Mandel-Brehm JoshChief Executive OfficerBuy6,060$10.00KForm 4
Sep 11, 2025Gold KellyChief Financial OfficerBuy6,060$10.00KForm 4
Sep 11, 20255AM Partners VI, LLC & 5AM Ventures VI, L.P. & 5AM Opportunities II (GP), LLC & 5AM Opportunities II, L.P. & 5AM Partners VII, LLC & 5AM Ventures VII, L.P. & PARMAR KUSH10% OwnerBuy2,941,176$4.50MForm 4
Sep 11, 2025Schwab Andrew J.DirectorAward2,941,176$4.50MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related